The Baseline Power of GLP-1 When you inject a dual-agonist like Tirzepatide, you are deploying a sledgehammer to your metabolic system
Medical professionals emphasize that GLP-1 medications should never be viewed as a standalone treatment for addiction
If youve tried all these things and other methods and your side effects still continue, consult your doctor for advice
Additional emerging data further support the idea that hormonal status influences both weight loss responsiveness and body composition outcomes during GLP-1 therapy [17], consistent with the mechanistic picture of HRT restoring a metabolic environment that makes GLP-1 receptor agonists more effective
Next up: a possible obesity indication
Contrary to common knowledge, patients in the subgroup with a higher BMI did not show significant weight gain (WMD = 1.21 kg, 95% CI 1.24 to 3.60, P = 0.33, I 2 = 72%) and there were no significant differences between the subgroups ( P = 0.73) (Additional file 2: Fig